In triple‐negative breast cancer models, including in situ, distal, and metastatic models, this system enhanced T‐cell infiltration, promoted dendritic cell maturation, stimulated systemic immune responses, and effectively downregulated PD‐L1 expression, thereby inhibiting tumor progression. Here, CD274 is linked to neoplasm.